← Back to Search

Diagnostic Test

Accelerate Pheno for Bloodstream Infection

N/A
Waitlist Available
Research Sponsored by Accelerate Diagnostics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 days after randomization
Awards & highlights

Study Summary

This trial will test how well two devices work in identifying and testing for antimicrobial susceptibility in patients with positive blood cultures, as well as the impact on patient care and costs.

Eligible Conditions
  • Bloodstream Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 days after randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 days after randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Duration of anti-methicillin-resistant Staphylococcus aureus (MRSA) therapy
Duration of anti-pseudomonal β-lactam therapy

Trial Design

2Treatment groups
Active Control
Group I: Accelerate PhenoActive Control1 Intervention
Fast ID and AST of positive blood culture bottles using the Accelerate PhenoTest™ BC kit with the Accelerate Pheno™ System
Group II: Standard of CareActive Control1 Intervention
Standard culture and AST of positive blood culture bottles plus the Verigene® BC-GP/GN

Find a Location

Who is running the clinical trial?

Accelerate Diagnostics, Inc.Lead Sponsor
6 Previous Clinical Trials
9,240 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still availability slots for participants in this experiment?

"Clinicaltrials.gov informs us that, as of April 20th 2022, this medical trial is no longer in the recruitment phase. This study was first posted on May 23rd 2019 and has since concluded its search for participants. Nevertheless, 163 other trials are currently recruiting volunteers."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Genotypic Versus Phenotypic Susceptibility Testing of Positive Blood Cultures
2019. "Genotypic Versus Phenotypic Susceptibility Testing of Positive Blood Cultures". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03744728.
~133 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top